Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overview of CD24 as a new molecular marker in ovarian cancer

14 Oct 2018

Abstract excerpt

Ovarian cancer (OC) is the fifth leading cause of cancer-related death among women. The high mortality rate is due to lack of early symptoms, late diagnosis, limited treatment options, and also emerging of drug resistance. Todays, molecular markers have become promising in tumor-targeted therapy. Several molecular markers have been known in OC immunotherapy. Identification of the specific molecular markers with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Immunotherapy and Immune Responses
Share to Lung Cancer Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30317611
DOI: 10.1002/jcp.27581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overview of CD24 as a new molecular marker in ovarian cancerPMID 30317611Read ↗

Novel insights into the function of CD24 : A driving force in cancerSemantic proximity Read ↗

Surprising magic of CD24 beyond cancerSemantic proximity Read ↗

Immunotherapeutic Approaches in Ovarian CancerSemantic proximity Read ↗

Applications of Proteomics in Ovarian Cancer: Dawn of a New EraSemantic proximity Read ↗

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevanceSemantic proximity Read ↗

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast CancerSemantic proximity Read ↗

CD63 as a potential biomarker for patients with ovarian cancerSemantic proximity Read ↗

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunctionSemantic proximity Read ↗

Ovarian cancer biomarkers for molecular biosensors and translational medicine.Semantic proximity Read ↗

Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel TherapiesSemantic proximity Read ↗

CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cellsSemantic proximity Read ↗

Unravelling CD24 ‐ Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.